Grand River Aseptic Manufacturing

10/09/2026

Grand River Aseptic Manufacturing is exhibiting at PODD in Boston on October 29–30, 2026. Visit us at booth 623 to connect with our team and discuss aseptic fill-finish strategies for liquid and lyophilized vials, syringes, and cartridges, along with the collaboration and technical expertise needed to support clinical through commercial supply.

10/06/2026

Grand River Aseptic Manufacturing and BD (Becton, Dickinson and Company) announce fill-finish services supporting the BD Libertas™ Wearable Injector

Through the strategic alliance between GRAM and BD, we have successfully established 5 mL and 10 mL cartridge fill-finish capability for the BD Libertas™ Wearable Injector.

✅ 5 mL and 10 mL programming created and qualified
✅ Vacuum-assisted stoppering capability established
✅ Multiple production runs completed successfully
✅ Ready to support customer programs utilizing the BD Libertas platform

BD Libertas™ Wearable Injector is designed to help pharma transition therapies from IV to subcutaneous administration and simplify delivery of high-dose subcutaneous drugs where the drug delivery solution needs to address delivery time or tolerability objectives.

Together with GRAM, this milestone strengthens the infrastructure available to pharmaceutical innovators developing next-generation biologics requiring convenient, high-volume and high-viscosity subcutaneous delivery.

We're excited to help customers move faster from development to commercialization with an integrated fill-finish and wearable injector solution!

Contact us to learn more about how this partnership is shaping the future of biologic therapies and empowering patients worldwide.

10/01/2026

Sterile fill-finish Contract Development and Manufacturing Organizations (CDMOs) play a crucial role in the pharmaceutical supply chain. Their function has evolved beyond merely offering manufacturing capacity. Pharmaceutical companies increasingly seek partners that combine technical expertise, modern aseptic manufacturing capabilities, regulatory compliance, operational reliability, and the ability to execute complex technology transfers.

This presents both significant opportunities and substantial responsibilities.

In the latest issue of PharmaNetwork magazine, Grand River Aseptic Manufacturing CEO Denis Johnson discusses what the next generation of aseptic manufacturing holds. ➡️ https://hubs.la/Q04yQqNj0

09/29/2026

Insights from GRAM at CPHI Milan: Navigating the Future of Sterile Manufacturing

As biologics manufacturing evolves, Contract Development and Manufacturing Organizations are becoming increasingly pivotal. At CPHI Milan, October 6 – 8, 2026, Grand River Aseptic Manufacturing will showcase its innovative capabilities, particularly in aligning manufacturing capacity and capabilities with clients’ long-term goals.

Explore these exciting advancements and how they can benefit your pharmaceutical journey at booth !

09/25/2026

CDMO project management is evolving. Clients still expect strong ex*****on, but they also need strategic partners who anticipate risk, connect technical teams, and maintain visibility from day one. In this video interview, Rachel Wilson, Director of Business Operations at Grand River Aseptic Manufacturing, shares how communication, transparency, and clear expectations strengthen sterile fill-finish partnerships.

Watch to learn how early stakeholder alignment, tailored reporting, and proactive risk mitigation can support commercial readiness and make project management more data-driven through software, AI, and automation.

https://hubs.la/Q04yktpR0

09/21/2026

Grand River Aseptic Manufacturing is exhibiting at CDMO Live Americas on October 20–21, 2026, at the Sheraton Boston. We look forward to connecting with pharmaceutical and biotech leaders to discuss how early planning, strong collaboration, and scalable aseptic fill-finish strategies can help support smoother technology transfers and long-term commercial readiness.

08/27/2026

💡 The transition from clinical trials to full commercial supply in advanced therapies is a complex process that requires exceptional operational agility and strategic planning. At the heart of this journey is the importance of aligning manufacturing capacity with long-term goals and proactively managing risks.

Flexibility in manufacturing processes and robust facility design is essential. Incorporating redundancy in critical systems and leveraging digital technologies can help maintain product quality and consistency, especially during transitions.

Collaboration among development, manufacturing, and quality teams plays a pivotal role in minimizing bottlenecks, particularly during technology transfer. By identifying constraints early and ensuring supply chain readiness, we can pave the way for successful product commercialization.

Hear from our CFO as he shares insights that de-risk the path to commercial supply:
https://hubs.la/Q04v6NhP0

Aligning manufacturing capacity with long-term client goals ensures products transition smoothly with consistent performance at commercial volumes.

08/07/2026

In the latest episode of the to Market podcast, Johnson, CEO of GRAM, emphasizes the importance of understanding the unique challenges that the pharmaceutical industry faces during drug launches, shares insight on why GRAM focuses on sterile filling instead of trying to be a jack-of-all-trades, and much more!

Denis's extensive career gives him a unique perspective that enables him to anticipate client needs and implement robust processes to overcome manufacturing challenges that could delay market entry. It's not just about having state-of-the-art production lines; it's crucial to operate them effectively within a framework that ensures safe and successful delivery. Contract Development and Manufacturing Organizations (CDMOs) require skilled professionals who can successfully manage multiple tech transfers each year while maintaining compliance and operational excellence.

🎤 Listen to the full podcast at https://hubs.la/Q04shBPJ0

Or, wherever you get your podcasts.

08/06/2026

We’re heading to CPHI Milan 2026!
Meet the Grand River Aseptic Manufacturing team in Milan and discover how we’re advancing pharmaceutical manufacturing.
📌 Find us at Stand 8A26
Let’s connect, share insights, and explore how we can support your next project. We look forward to meeting you!

07/08/2026

🌟Embracing Change in Sterile Manufacturing

As our industry evolves, the updates to Annex 1 highlight a shift towards proactive contamination control and comprehensive compliance strategies.

At Grand River Aseptic Manufacturing (GRAM), we've adopted a holistic approach, emphasizing:

✅ Comprehensive Contamination Control Strategies
✅ Continuous Process Validation
✅ Integration of Quality Risk Management
✅ Innovative Facility Design
✅ Enhanced Data Integrity and Transparency

These initiatives strengthen our partnerships through transparency and operational efficiency. Prioritizing quality for client products and the people who use them remains our #1.

https://hubs.la/Q04mtYny0